David Moeny

564 total citations
13 papers, 420 citations indexed

About

David Moeny is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Moeny has authored 13 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 2 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Moeny's work include Reproductive Health and Contraception (3 papers), Pregnancy and Medication Impact (3 papers) and Maternal and fetal healthcare (2 papers). David Moeny is often cited by papers focused on Reproductive Health and Contraception (3 papers), Pregnancy and Medication Impact (3 papers) and Maternal and fetal healthcare (2 papers). David Moeny collaborates with scholars based in United States, Thailand and Netherlands. David Moeny's co-authors include Diane K. Wysowski, Vicky Borders‐Hemphill, Christian Hampp, Christine Nguyen, Hylton V. Joffe, Mark Hirsch, Allen Brinker, Joseph M. Tonning, Jonathan G. Levine and Mark Avigan and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Addiction.

In The Last Decade

David Moeny

12 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Moeny United States 7 256 122 82 59 33 13 420
Karen Bracken Australia 8 306 1.2× 84 0.7× 155 1.9× 30 0.5× 64 1.9× 26 429
Kang Liu China 12 134 0.5× 83 0.7× 52 0.6× 22 0.4× 66 2.0× 23 452
Ali Shamsa Iran 10 109 0.4× 95 0.8× 52 0.6× 18 0.3× 43 1.3× 33 351
Kyriakos Kazakos Greece 11 223 0.9× 83 0.7× 34 0.4× 95 1.6× 30 0.9× 28 474
Jeffrey A. Wald United States 12 231 0.9× 98 0.8× 53 0.6× 134 2.3× 32 1.0× 13 559
Paul Novotny United States 8 305 1.2× 57 0.5× 30 0.4× 58 1.0× 27 0.8× 17 572
Qing Yu China 17 61 0.2× 228 1.9× 92 1.1× 66 1.1× 6 0.2× 51 634
John B. Adams Australia 15 294 1.1× 242 2.0× 12 0.1× 36 0.6× 51 1.5× 25 736
Jung‐Nien Lai Taiwan 11 45 0.2× 70 0.6× 44 0.5× 42 0.7× 62 1.9× 31 415

Countries citing papers authored by David Moeny

Since Specialization
Citations

This map shows the geographic impact of David Moeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Moeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Moeny more than expected).

Fields of papers citing papers by David Moeny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Moeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Moeny. The network helps show where David Moeny may publish in the future.

Co-authorship network of co-authors of David Moeny

This figure shows the co-authorship network connecting the top 25 collaborators of David Moeny. A scholar is included among the top collaborators of David Moeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Moeny. David Moeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Osborne, Vicki, Amie Goodin, Joshua D. Brown, et al.. (2024). Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and Drug Safety. 33(4). e5789–e5789.
2.
Lardieri, Allison, Karen Konkel, S. Christopher Jones, et al.. (2021). Pentosan associated retinal pigmentary changes: FDA’s perspective on an emerging postmarketing safety finding. International Urogynecology Journal. 32(11). 2891–2897. 3 indexed citations
3.
Eworuke, Efe, Laura Hou, Rongmei Zhang, et al.. (2021). Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin. Drug Safety. 44(7). 753–763. 6 indexed citations
4.
Shinde, Mayura, Corinne Woods, Christina Y. Chang, et al.. (2021). Utilization of hydroxyprogesterone caproate among pregnancies with live birth deliveries in the sentinel distributed database. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25). 6291–6296. 3 indexed citations
5.
Liu, Wei, Corinne Woods, Jie Li, et al.. (2020). Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States. Pharmacoepidemiology and Drug Safety. 30(2). 126–134. 6 indexed citations
6.
Li, Jie, David Moeny, Wei Liu, et al.. (2018). Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives. JAMA Internal Medicine. 178(11). 1482–1482. 9 indexed citations
7.
Eworuke, Efe, et al.. (2017). The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate. Pharmacoepidemiology and Drug Safety. 26(7). 827–836. 3 indexed citations
8.
Eworuke, Efe, Vaishali Popat, & David Moeny. (2017). Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning. Journal of Clinical Pharmacy and Therapeutics. 42(4). 483–494. 3 indexed citations
9.
Nguyen, Christine, et al.. (2015). Testosterone and “Age-Related Hypogonadism” — FDA Concerns. New England Journal of Medicine. 373(8). 689–691. 138 indexed citations
10.
Hampp, Christian, Vicky Borders‐Hemphill, David Moeny, & Diane K. Wysowski. (2014). Use of Antidiabetic Drugs in the U.S., 2003–2012. Diabetes Care. 37(5). 1367–1374. 173 indexed citations
11.
Zhou, Esther H., Sigal Kaplan, Andrew D. Mosholder, et al.. (2013). Antidepressant medication dispensing among montelukast initiators. Journal of Asthma. 50(9). 990–995. 9 indexed citations
12.
13.
Meyer, Tamra E., Lockwood G. Taylor, David J. Graham, et al.. (2012). Neuropsychiatric events in varenicline and nicotine replacement patch users in the M ilitary H ealth S ystem. Addiction. 108(1). 203–210. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Bracken Breakdown of academic impact, for papers by Kang Liu Breakdown of academic impact, for papers by Ali Shamsa Breakdown of academic impact, for papers by Kyriakos Kazakos Breakdown of academic impact, for papers by Jeffrey A. Wald Breakdown of academic impact, for papers by Paul Novotny Breakdown of academic impact, for papers by Qing Yu Breakdown of academic impact, for papers by John B. Adams Breakdown of academic impact, for papers by Jung‐Nien Lai
Rankless by CCL
2026